Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models-Reference-Cited by-同舟云学术

Preclinical evaluation for engraftment of CD34+ cells gene-edited at the sickle cell disease locus in xenograft mouse and non-human primate models

Published:2021-04 Issue:4 Volume:2 Page:100247
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Uchida Naoya^ORCID,Li Linhong,Nassehi Tina,Drysdale Claire M.,Yapundich Morgan,Gamer Jackson,Haro-Mora Juan J.,Demirci Selami,Leonard Alexis,Bonifacino Aylin C.,Krouse Allen E.,Linde N. Seth,Allen Cornell,Peshwa Madhusudan V.,De Ravin Suk See,Donahue Robert E.,Malech Harry L.,Tisdale John F.

Funder

NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference62 articles.

1. Management of sickle cell disease;Steinberg;N. Engl. J. Med.,1999

2. A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy;Bridges;Blood,1996

3. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease;Ataga;N. Engl. J. Med.,2017

4. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease;Niihara;N. Engl. J. Med.,2018

5. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype;Hsieh;JAMA,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR technology in human diseases;MedComm;2024-07-29

2. Challenges and innovations in hematopoietic stem cell transplantation: exploring bone marrow niches and new model systems;BMB Reports;2024-07-05

3. A bioinformatic analysis of gene editing off-target loci altered by common polymorphisms, using ‘PopOff’;Journal of the Royal Society of New Zealand;2024-05-09

4. The difficult translational pathway from animal models to patients;Cell Stem Cell;2024-04

5. A simultaneous knockout knockin genome editing strategy in HSPCs potently inhibits CCR5- and CXCR4-tropic HIV-1 infection;Cell Stem Cell;2024-04